Estradiol Rapid Quantitative Test - India CDSCO Medical Device Registration

Estradiol Rapid Quantitative Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000164_f3105fc20b7f21d4d7b756f4d6fc9a23_40056b7b656dd930ebd38e6526c4a856. This device is marketed under the brand name E2. The license holder is M/s Avantor Performance Materials India Ltd, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class B

Estradiol Rapid Quantitative Test

UID: IMP/IVD/2022/000164_f3105fc20b7f21d4d7b756f4d6fc9a23_40056b7b656dd930ebd38e6526c4a856

Brand Name

License Holder

M/s Avantor Performance Materials India Ltd

Device Class

Class B

Approving Authority

CDSCO

Product Information

The Estradiol (E2) Rapid Quantitative Test is a fluorescence immunoassay used along with FIA Meters (E2) is for quantitative measurement of Estradiol (E2) in human whole blood, serum or plasma. The test is used as an aid to the evaluation of ovarian diseases. For in vitro diagnostic use only. For professional use only